Curaleaf Holdings (CURA.TO) Stock Analysis & Winston Score

Curaleaf is one of the largest cannabis companies in the United States. It grows, processes, and sells marijuana products — including flower, edibles, vapes, and oils — under brands like Select. Its customers are adult consumers buying cannabis for medical or recreational use, sold through a network of Curaleaf-branded retail dispensaries across many U.S. states. Curaleaf makes money by selling cannabis products directly to consumers through its own stores, and also sells wholesale to other dispensaries. It operates in roughly 20 U.S. states, making it one of the biggest multi-state operators in the country. Its large scale and owned supply chain give it some cost advantages over smaller rivals, but the company faces a serious ongoing risk: cannabis remains illegal under U.S. federal law, which blocks access to normal banking, creates heavy tax burdens under IRS Section 280E, and has kept the stock listed in Canada rather than on a major U.S. exchange. Federal rescheduling of cannabis could significantly change the company's financial picture.